Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by GoldMemberTon Nov 02, 2021 3:13pm
159 Views
Post# 34078737

27 cents. You don’t need to be an expert stockhouse troll

27 cents. You don’t need to be an expert stockhouse troll

to see that 

they pulled a fast one for a financing and haven't had a significant non fluff piece of news since. That in and of itself is just akin spitting in investors faces.

they haven't spun out dialco as promised

they don't have a partner that they claimed they would have for Dialco.

no news on continued "heightened enrolment"

no start of dimi trial

The company did not live up to the promise of 15 hospitals recruiting by the end of Q3

investor presentation says 60% enrolment for PMX by DECEMBER but on clinicaltrials.gov it's slated for March (I bet that will get moved too). 

literally can not get the company to pick up their phone which actually aside from here does not exist anywhere else. Even the worst of companies have someone for investors to talk to. Most of the time the CEO does it to save on cost but in this case they can't even spend 50k on a recent grad. 

<< Previous
Bullboard Posts
Next >>